Press Releases from DelveInsight Business Research LLP (4839 total)
Urinary Tract Obstruction Treatment Devices Market Dynamics 2032: Research Trend …
DelveInsight's Urinary Tract Obstruction Treatment Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Urinary Tract Obstruction Treatment Devices Companies…
DelveInsight's Portable Ultrasound Bladder Scanner Market Report 2032: In-Depth …
DelveInsight's Portable Ultrasound Bladder Scanner Market Insights Report 2032 provides the current and forecast market analysis, individual leading Portable Ultrasound Bladder Scanner Companies market shares,…
Disposable Endoscopes Market Report 2032: Key Market Drivers, Competitive Landsc …
DelveInsight's Disposable Endoscopes Market Insights Report 2032 provides the current and forecast market analysis, individual leading Disposable Endoscopes Companies market shares, challenges, Disposable Endoscopes Market…
DelveInsight's Comprehensive Analysis of the Venous Thromboembolism Treatment De …
DelveInsight's Venous Thromboembolism Treatment Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Venous Thromboembolism Treatment Devices Companies market shares,…
Antibody Discovery Market Size Report 2025: Current Landscape, Emerging Trends, …
DelveInsight's Antibody Discovery Market Insights Report 2032 provides the current and forecast market analysis, individual leading Antibody Discovery Companies market shares, challenges, Antibody Discovery Market…
Non Muscle Invasive Bladder Cancer Triple Negative Breast Cancer Pipeline Drugs …
DelveInsight's "Triple Negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 165+ companies and 170+ pipeline drugs in the Triple Negative Breast Cancer…
Non Muscle Invasive Bladder Cancer Pipeline Drugs Report 2025 highlights pharmac …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder…
Advanced Endometrial Cancer Pipeline 2025 analyzes new therapies and advancement …
DelveInsight's, "Advanced Endometrial Cancer Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Advanced Endometrial Cancer pipeline landscape. It…
Complicated Urinary Tract Infections Pipeline 2025 highlights innovative treatme …
DelveInsight's "Complicated Urinary Tract Infections Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in the Complicated Urinary Tract Infections…
Hidradenitis Suppurativa Pipeline 2025 explores emerging therapies and ongoing c …
DelveInsight's, "Hidradenitis Suppurativa Pipeline Insight 2025" report provides comprehensive insights about 24+ companies and 24+ pipeline drugs in Hidradenitis Suppurativa pipeline landscape. It covers the…
Fallopian Tube Cancer Pipeline 2025 highlights the progress of novel therapeutic …
DelveInsight's, "Fallopian Tube Cancer Pipeline Insight 2025" report provides comprehensive insights about 70+ Fallopian tube cancer companies and 70+ pipeline drugs in Fallopian Tube Cancer…
Advanced Hepatocellular Carcinoma Pipeline 2025 provides an in-depth analysis of …
DelveInsight's, "Advanced Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Advanced Hepatocellular Carcinoma pipeline landscape. It…
Brain Metastases Pipeline 2025 explores the evolving landscape of investigationa …
DelveInsight's, "Brain Metastases Pipeline Insights 2025" report provides comprehensive insights about 40+ Brain Metastases companies and 45+ pipeline drugs in Brain Metastases pipeline landscape. It…
Cutaneous T-Cell Lymphoma Pipeline Insights Report 2025: In-Depth Analysis of R& …
DelveInsight's "Cutaneous T-cell lymphoma Pipeline Insight 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Cutaneous T-cell lymphoma pipeline landscape.…
Non-Small Cell Lung Cancer Pipeline Drugs Report 2025: Unveiling the Next-Genera …
DelveInsight's, Non-Small-Cell Lung Cancer (NSCLC) Pipeline Insights 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Non-Small-Cell Lung cancer (NSCLC) pipeline…
Acute Lymphocytic Leukemia Pipeline 2025: Key Insights into Novel Mechanisms, On …
DelveInsight's "Acute Lymphocytic Leukemia Pipeline Insight 2025" report provides comprehensive insights about 125+ companies and 130+ pipeline drugs in the Acute Lymphocytic Leukemia pipeline landscape.…
Multiple Myeloma Pipeline Outlook Report 2025: A Comprehensive Review of Drugs i …
DelveInsight's "Multiple Myeloma Pipeline Insights 2025" report provides comprehensive insights about 75+ Multiple Myeloma Companies and 80+ pipeline drugs in the Multiple Myeloma pipeline landscape.…
ESCLC Pipeline Drugs Report 2025: Exploring the Emerging Therapeutics, Innovativ …
DelveInsight's, "Extensive-Stage Small Cell Lung Cancer (ESCLC) Pipeline Insight, 2025" report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Extensive-Stage Small Cell…
Epidermolysis Bullosa Pipeline Drugs 2025 Report: Uncovering Key Drug Developmen …
DelveInsight's "Epidermolysis Bullosa Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 21+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the…
Cough in Idiopathic Pulmonary Fibrosis Pipeline 2025 Report: Detailed Overview o …
DelveInsight's "Cough in Idiopathic Pulmonary Fibrosis (IPF) Pipeline Insight, 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cough in Idiopathic…
Vascular Dementia Pipeline Drugs Report 2025: Insightful Analysis of Upcoming Th …
DelveInsight's "Vascular Dementia Pipeline Insight, 2025," report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Vascular Dementia pipeline landscape. It covers the…
RIPK1 Inhibitor Pipeline Insights Report 2025: Complete Analysis of Emerging The …
DelveInsight's, "RIPK1 inhibitor Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in RIPK1 inhibitor pipeline landscape. It covers the…
HR Positive/ HER2 Negative Breast Cancer Pipeline Outlook Report 2025: Extensive …
DelveInsight's, "HR Positive/ HER2 Negative Breast Cancer Pipeline Insight, 2025," report provides comprehensive insights about 50+ companies and 53+ pipeline drugs in HR Positive/ HER2…
Mesothelioma Pipeline Drugs Report 2025 Overview: Comprehensive Analysis of Clin …
DelveInsight's "Mesothelioma Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the mesothelioma pipeline landscape. It covers the Mesothelioma…
Marginal Zone Lymphoma Pipeline Insights Report 2025 Highlights Emerging Therapi …
DelveInsight's, "Marginal Zone Lymphoma Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Marginal Zone Lymphoma pipeline landscape. It…
Esophageal Squamous Cell Carcinoma Pipeline Drugs Report 2025 by DelveInsight: I …
DelveInsight's "Esophageal Squamous Cell Carcinoma Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Esophageal Squamous Cell Carcinoma pipeline…
Overactive Bladder Pipeline Outlook Report 2025: Detailed Analysis of Novel Ther …
DelveInsight's "Overactive Bladder Pipeline Insights 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Overactive Bladder pipeline landscape. It covers the…
Dystrophic Epidermolysis Bullosa Pipeline Drugs Report 2025: Comprehensive Insig …
DelveInsight's, "Dystrophic Epidermolysis Bullosa Pipeline Insight, 2025," report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Dystrophic Epidermolysis Bullosa pipeline landscape. It…
ER+/ HER2-VE Breast Cancer Pipeline 2025 Report by DelveInsight: Tracking Emergi …
DelveInsight "ER positive, HER2 negative Breast Cancer Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in the ER positive,…
Diffuse Large B-Cell Lymphoma Pipeline Drugs Report 2025: Mapping Future Therapi …
DelveInsight's "Diffuse Large B-Cell Lymphoma Pipeline Insights 2025" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in the Diffuse Large B-Cell Lymphoma…
Pulmonary Fibrosis Pipeline Drugs Report 2025 by DelveInsight: Latest Breakthrou …
DelveInsight's "Pulmonary Fibrosis Pipeline Insight 2025" report provides comprehensive insights about 110+ companies and 140+ pipeline drugs in the Pulmonary Fibrosis pipeline landscape. It covers…
DelveInsight's Osteoarthritis Pipeline 2025 Report: A Deep Dive into Therapies i …
DelveInsight's, "Osteoarthritis Pipeline Insights 2025" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in Osteoarthritis pipeline landscape. It covers the pipeline drug…
Advanced Renal Cell Carcinoma Pipeline 2025 by DelveInsight: Comprehensive Insig …
DelveInsight's "Advanced Renal Cell Carcinoma Pipeline Insights 2025" report provides comprehensive insights about 50+ companies and 60+ pipeline drugs in Advanced Renal Cell Carcinoma pipeline…
HER2-Positive Breast Cancer Pipeline Drugs Report 2025 Providing a Holistic View …
DelveInsight's "HER2 Positive Breast Cancer Pipeline Insight, 2025" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in HER2 Positive Breast Cancer pipeline…
Chronic Lymphocytic Leukemia Pipeline Drugs Report 2025 by DelveInsight Offering …
DelveInsight's "Chronic Lymphocytic Leukemia Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia pipeline landscape. It…
Anal Cancer Pipeline 2025 Report by DelveInsight Highlighting Current R&D Effort …
DelveInsight's "Anal Cancer Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 8+ pipeline drugs in Anal Cancer pipeline landscape. It covers the…
Small Cell Lung Cancer Pipeline Outlook Report 2025: Comprehensive Insights into …
DelveInsight's "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Small Cell Lung Cancer…
Myelofibrosis Pipeline 2025 by DelveInsight: An In-Depth Outlook on Emerging The …
DelveInsight's, "Myelofibrosis Pipeline Insights 2025" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline…
Hepatocellular Carcinoma Pipeline Drugs Report 2025: Pharma Collaborations, Brea …
DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the…
Colorectal Cancer Pipeline Insights Report 2025: Cutting-Edge Research, Drug App …
DelveInsight's "Colorectal Cancer Pipeline Insight 2025" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the…
Idiopathic Pulmonary Fibrosis Pipeline Outlook Report 2025: Key Clinical Trials, …
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insights 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It…
Niemann-Pick Type C Pipeline Drugs Report 2025 by DelveInsight: Innovative Drug …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline…
Small Cell Lung Cancer Pipeline 2025: Emerging Therapies, Novel Targets, and Ong …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline…
Myelofibrosis Pipeline Report 2025 by DelveInsight: Key Insights into Clinical S …
DelveInsight's "Myelofibrosis Pipeline Insight" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in the Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline…
Hemophilia Pipeline Landscape Report 2025: DelveInsight's Exclusive Report on Cu …
DelveInsight's "Hemophilia Pipeline Insight" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Hemophilia pipeline landscape. It covers the Hemophilia pipeline…
DelveInsight's NMIBC Pipeline 2025: Unveiling Drug Development Progress, Clinica …
DelveInsight's, "Non Muscle Invasive Bladder Cancer Pipeline Insight" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Non Muscle Invasive Bladder Cancer…
Hearing Loss Pipeline 2025 by DelveInsight: Exploring Novel Mechanisms of Action …
DelveInsight's "Hearing Loss Pipeline Insight" report provides comprehensive insights about 32+ companies and 35+ pipeline drugs in Hthe earing Loss pipeline landscape. It covers the…
Exosomes Pipeline Insights 2025: A Comprehensive Analysis by DelveInsight Highli …
DelveInsight's, "Exosomes Pipeline Insight" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Exosomes pipeline landscape. It covers the Exosomes pipeline drug…
DelveInsight's Spasticity Pipeline 2025 Report: Tracking Emerging Drugs, Key Cli …
DelveInsight's "Spasticity Pipeline Insight" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Sthe pasticity pipeline landscape. It covers the Spasticity pipeline…
Endometriosis Pipeline Drugs Report 2025: DelveInsight's In-Depth Review of Nove …
DelveInsight's, "Endometriosis Pipeline Insight" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Endometriosis pipeline landscape. It covers the pipeline drug profiles,…
Go To Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
